|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 125 | 2005 | Fraud detection | BUYSE, Marc | Book Section | B3 |
| 126 | 2005 | The evaluation of surrogate endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc | Book | B1 |
| 127 | 2005 | Multicenter trials | BUYSE, Marc | Book Section | B3 |
| 128 | 2005 | Notation and motivating studies | MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 129 | 2005 | A meta-analytic validation framework for continuous outcomes | MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 130 | 2005 | A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancer | BURZYKOWSKI, Tomasz; Piccart, MJ; Sledge, G; Carmichael, J; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Therasse, P; BUYSE, Marc | Journal Contribution | M |
| 131 | 2005 | Effects of taxanes alone or in combination with anthracyclines on tumor response, progression-free survival and overall survival in first-line chemotherapy of patients with metastatic breast cancer: an analysis of 4,256 patients randomized in 12 trials | Piccart, MJ; BURZYKOWSKI, Tomasz; Sledge, G; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Carmichael, J; BUYSE, Marc; Therasse, P | Journal Contribution | M |
| 132 | 2005 | Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 tandomized trials | Sargent, Daniel J.; Wieand, Harry S.; Haller, Daniel G.; Gray, Richard; Benedetti, Jacqueline; BUYSE, Marc; Labianca, Roberto; Seitz, Jean Francois; O'Callaghan, Christopher J.; Francini, Guido; Grothey, Axel; O'Connell, Michael; Catalano, Paul J.; Blanke, Charles D.; Kerr, David; Green, Erin; Wolmark, Norman; André, Thierry; Goldberg, Richard M.; De Gramont, Aimery | Journal Contribution | A1 |
| 133 | 2005 | Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials. | BUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, K; Michiels, Stefan; Pignon, JP; Piedbois, P | Journal Contribution | M |
| 134 | 2004 | Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints | ALONSO ABAD, Ariel; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena; SHKEDY, Ziv; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BUYSE, Marc | Journal Contribution | A1 |
| 135 | 2004 | A perspective on surrogate endpoints in controlled clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; BUYSE, Marc | Journal Contribution | A1 |
| 136 | 2004 | Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials | Sakamoto, J.; Ohashi, Y.; Hamada, C.; BUYSE, Marc; BURZYKOWSKI, Tomasz; Piedbois, P. | Journal Contribution | A1 |
| 137 | 2004 | FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study | Tournigand, Christophe; André, Thierry; Achille, Emmanuel; Lledo, Gérard; Flesh, Michel; Mery-Mignard, Dominique; Quinaux, Emmanuel; Couteau, Corinne; BUYSE, Marc; Ganem, Gérard; Landi, Bruno; Colin, Philippe; Louvet, Christophe; de Gramont, Aimery | Journal Contribution | A1 |
| 138 | 2004 | Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis | BUYSE, Marc; et al | Journal Contribution | A1 |
| 139 | 2004 | The validation of surrogate endpoints by using data from randomized clinical trials: a case-study in advanced colorectal cancer | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc | Journal Contribution | A1 |
| 140 | 2003 | Overall survival is not a realistic endpoint for clinical trials in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer | Di Leo, A.; Bleiberg, H.; BUYSE, Marc | Journal Contribution | A1 |
| 141 | 2003 | Validation of biomarkers as surrogates for clinical endpoints | BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc; RENARD, Didier; BURZYKOWSKI, Tomasz; GEYS, Helena; MOLENBERGHS, Geert | Book Section | B3 |
| 142 | 2003 | Comparaison entre LV5FU2 bi-mensuel et FUFOL mensuel pendant 24 ou 36 semaines en traitement adjuvant des cancers du colon stade II et III: résultats à 4 ans d'une étude randomisée | BUYSE, Marc; André, Thierry; Artru, P.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Piedbois, P.; Flesch, M.; Tubiana-Mathieu, N.; de Gramont, A. | Journal Contribution | A2 |
| 143 | 2003 | Simplified hierarchical linear models for the evaluation of surrogate endpoints | TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; RENARD, Didier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Parmar, Mahesh; Stijnen, Theo; Wolfinger, Russ | Journal Contribution | A1 |
| 144 | 2003 | Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer | BUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, Jan | Journal Contribution | A1 |
| 145 | 2003 | Validation of a longitudinally measured surrogate for a time-to-event endpoint | RENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc | Journal Contribution | A1 |
| 146 | 2003 | Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial | BUYSE, Marc; André, Thierry; Colin, P.; Liouvet, C.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Colbert, N.; Boaziz, C.; Piedbois, P.; Tubiana-Mathieu, N.; Boutan-Laroze, A.; Flesch, M.; Billau, V.; de Gramont, A. | Journal Contribution | A1 |
| 23 | 2002 | Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early cancer: first results of the ATAC randomized trial | BUYSE, Marc | Journal Contribution | A1 |
| 24 | 2002 | Statistical challenges in the evaluation of surrogate endpoints in randomized trials | MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 25 | 2002 | Challenges in the methodology for the validation of surrogate endpoints in randomized trials | MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz | Proceedings Paper | C2 |
| 26 | 2002 | The role of colony stimulating factors in small cell cancer: why the question is still unresolved | Trillet-Lenoir, V.; Piedbois, R.; BUYSE, Marc | Journal Contribution | A1 |
| 27 | 2002 | Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer | DiLeo, A.; BUYSE, Marc | Journal Contribution | A1 |
| 28 | 2002 | Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomes | RENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 29 | 2001 | Methodology for the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 30 | 2001 | Methodology of the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 31 | 2001 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Journal Contribution | A1 |
| 32 | 2001 | Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer | BUYSE, Marc; Thirion, Pierre; Carlson, Robert; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 33 | 2001 | Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes | MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc | Journal Contribution | A1 |
| 34 | 2001 | Should Dukes' B patients receive adjuvant therapy? A statistical perspective | BUYSE, Marc; Piedbois, P | Journal Contribution | A1 |
| 35 | 2000 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Proceedings Paper | C1 |
| 36 | 2000 | Randomized designs for early trials of new cancer treatments - An overview | BUYSE, Marc | Journal Contribution | A1 |
| 37 | 2000 | Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis | BUYSE, Marc; Thirion, Pierre; Carlson, Robert W.; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 38 | 2000 | Meta-analysis: Methods, strengths, and weaknesses | BUYSE, Marc; Piedbois, P; Piedbois, Y; Carlson, RW | Journal Contribution | A1 |
| 39 | 2000 | R-2: A useful measure of model performance when predicting a dichotomous outcome | BUYSE, Marc | Journal Contribution | A1 |
| 40 | 2000 | Fraud in medical research: An international survey of biostatisticians | Ranstam, J.; BUYSE, Marc; George, S.L.; Evans, S.; Geller, N.; Scherrer, B.; LESAFFRE, Emmanuel; Murray, G.; Edler, L.; Hutton, J.; Colton, T.; Lachenbruch, P. | Journal Contribution | A1 |
| 41 | 2000 | Statistical validation of surrogate endpoints: problems and proposals | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 42 | 2000 | Corrigendum to "The validation of surrogate endpoints in randomized experiments" | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 43 | 2000 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 44 | 1999 | The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials | BUYSE, Marc; George, SL; Evans, S; Geller, NL; Ranstam, J; Scherrer, B; LESAFFRE, Emmanuel; Murray, G; Edler, L; Hutton, J; Colton, T; Lachenbruch, P; Verma, BL | Journal Contribution | |
| 45 | 1999 | Meta-analyses of published results are unreliable | BUYSE, Marc; Carlson, RW; Piedbois, P | Journal Contribution | |
| 46 | 1999 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Proceedings Paper | |
| 47 | 1999 | The role of anthracyclines in epithelial ovarian cancer | Vermorken, J.B.; Harper, P.G.; BUYSE, Marc | Journal Contribution | |
| 48 | 1998 | Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production | Corazza, F.; Beguin, Y.; Bergman, P.; André, M.; Fersten, A.; DE VALCK, Chris; Fondu, P.; BUYSE, Marc; Saribau, E. | Journal Contribution | |
| 49 | 1998 | Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced coloractal cancer | BUYSE, Marc | Journal Contribution | |
| 50 | 1998 | Toxiicity of 5-fluorouacil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors | BUYSE, Marc | Journal Contribution | |
| 51 | 1998 | Homeopathy | BUYSE, Marc | Journal Contribution | |
| 52 | 1998 | Criteria for the validation of surrogate endpoints in randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert | Journal Contribution | |
| 53 | 1997 | The trials of Dr. Bernard Fisher: a European perspective on an American episode | Peto, R.; Collins, R.; Sackett, D.; Darbyshire, J.; Babiker, A.; BUYSE, Marc; Stewart, H.; Baum, M.; Goldhirsch, H.; Bonadonna, G.; Valagussa, P.; Rutqvist, L.; Elbourne, D.; Davies, C.; Dalesio, O.; Parmar, M.; Hill, C.; Clarke, M.; Gray, R.; Doll, R. | Journal Contribution | |
| 54 | 1997 | Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases | Pastorino, U.; BUYSE, Marc; Friedel, G.; Ginsberg, R.J.; Girard, P.; Goldstraw, P.; Johnston, M.; McCormack, P.; Pass, H.; Putman, J.B. | Journal Contribution | |
| 55 | 1997 | A biostatistical tribute to Ignaz Philip Semmelweis | BUYSE, Marc | Journal Contribution | |
| 56 | 1997 | Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer | Durand-Zaleski, I.; Roche, B.; BUYSE, Marc; Carlson, R.; O'Connell, M.J.; Rougier, P.; Chang, A.E.; Sondak, V.K.; Kemeny, M.M.; Allen-Merch, T.G.; Fagniez, P.L.; le Bourgeois, J.P.; Piedbois, P. | Journal Contribution | |
| 57 | 1997 | Letter to the editor: artificial neural networks | BUYSE, Marc; Piedbois, P. | Journal Contribution | |
| 58 | 1997 | Artificial neural networks | BUYSE, Marc; Piedbois, P | Journal Contribution | |
| 59 | 1997 | Critical issues in colorectal cancer trial design | Piedbois, P.; BUYSE, Marc; Pignon, J.P. | Journal Contribution | |
| 60 | 1997 | La randomisation dans les essais cliniques | BUYSE, Marc; Piedbois, P. | Journal Contribution | |
| 61 | 1996 | Le 5-fluorouracile...un vieux médicament? | Piedbois, P.; BUYSE, Marc; Gauthier, E.; le Bourgeois, J.P. | Journal Contribution | |
| 62 | 1996 | Etablissement d'une courbe de survie | BUYSE, Marc; Piedbois, P. | Journal Contribution | |
Loading...
5
0
5
0
false